Transcend Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Sell |
31,738
-28,606
| -47% | -$2.49M | 0.21% | 109 |
|
|
2025
Q1 | $5.42M | Sell |
60,344
-1,567
| -3% | -$141K | 0.39% | 52 |
|
|
2024
Q4 | $4.95M | Sell |
61,911
-9,644
| -13% | -$770K | 0.36% | 62 |
|
|
2024
Q3 | $6.44M | Sell |
71,555
-374
| -0.5% | -$33.7K | 0.43% | 52 |
|
|
2024
Q2 | $5.66M | Buy |
71,929
+2,219
| +3% | +$175K | 0.41% | 50 |
|
|
2024
Q1 | $6.08M | Buy |
69,710
+8,140
| +13% | +$709K | 0.49% | 41 |
|
|
2023
Q4 | $5.07M | Buy |
61,570
+3,304
| +6% | +$272K | 0.45% | 44 |
|
|
2023
Q3 | $4.57M | Buy |
58,266
+21,635
| +59% | +$1.7M | 0.45% | 46 |
|
|
2023
Q2 | $3.23M | Sell |
36,631
-784
| -2% | -$69.1K | 0.31% | 76 |
|
|
2023
Q1 | $3.02M | Buy |
37,415
+6,206
| +20% | +$500K | 0.31% | 78 |
|
|
2022
Q4 | $2.43M | Sell |
31,209
-5,829
| -16% | -$453K | 0.26% | 97 |
|
|
2022
Q3 | $2.99M | Sell |
37,038
-4,223
| -10% | -$341K | 0.33% | 74 |
|
|
2022
Q2 | $3.7M | Sell |
41,261
-9,827
| -19% | -$882K | 0.39% | 56 |
|
|
2022
Q1 | $5.67M | Buy |
51,088
+3,438
| +7% | +$381K | 0.51% | 39 |
|
|
2021
Q4 | $4.93M | Buy |
47,650
+4,621
| +11% | +$478K | 0.44% | 54 |
|
|
2021
Q3 | $5.34M | Buy |
+43,029
| New | +$5.34M | 0.48% | 43 |
|
|
2021
Q2 | – | Sell |
-43,295
| Closed | -$5.12M | – | 375 |
|
|
2021
Q1 | $5.12M | Sell |
43,295
-1,622
| -4% | -$192K | 0.62% | 31 |
|
|
2020
Q4 | $5.26M | Buy |
44,917
+10,553
| +31% | +$1.24M | 0.69% | 23 |
|
|
2020
Q3 | $3.57M | Buy |
34,364
+17,193
| +100% | +$1.79M | 0.65% | 36 |
|
|
2020
Q2 | $1.58M | Sell |
17,171
-1,461
| -8% | -$134K | 0.51% | 62 |
|
|
2020
Q1 | $1.69M | Buy |
18,632
+155
| +0.8% | +$14.1K | 0.51% | 57 |
|
|
2019
Q4 | $2.1M | Buy |
+18,477
| New | +$2.1M | 0.56% | 55 |
|